Dexamethasone for Severe COVID-19: How Does It Work at Cellular and Molecular Levels?
The coronavirus disease 2019 (COVID-19) caused by infection of the severe respiratory syndrome coronavirus-2 (SARS-CoV-2) significantly impacted human society. Recently, the synthetic pure glucocorticoid dexamethasone was identified as an effective compound for treatment of severe COVID-19. However,...
Main Authors: | Tomoshige Kino, Irina Burd, James H. Segars |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/13/6764 |
Similar Items
-
Thalidomide combined with short-term low-dose glucocorticoid therapy for the treatment of severe COVID-19: A case-series study
by: Yuping Li, et al.
Published: (2021-02-01) -
IMPACT DE L’HYPERCORTICISME SUR L’AXE GONADOTROPE FEMELLE
by: Ayrout, Mohsen
Published: (2018) -
COVID-19, adrenal gland, glucocorticoids, and adrenal insufficiency
by: Emin Murat Akbas, et al.
Published: (2021-03-01) -
Dexamethasone induces the expression of LRRK2 and α-synuclein, two genes that when mutated cause Parkinson’s disease in an autosomal dominant manner
by: Ji-Min Park, et al.
Published: (2013-09-01) -
Recent Updates on Corticosteroid Resistance in Asthma
by: Lipsa Panda, et al.
Published: (2018-09-01)